Single subcutaneous doses of zilebesiran significantly lower blood pressure for up to 6 months, suggesting potential for use as an effective antihypertensive with quarterly or biannual dosing.
Read the KARDIA-1 RCT:
https://t.co/gFFqCDyzB8
Excited to join the #JACCBTS social media team—it has quickly become a journal in which to find and publish high-quality cardiovascular research.
Follow the entire team for more great work published in #JACCBTS! @JeffHsuMD@VascRes@Jean_Wassenaar@JACCJournals
When Einthoven introduced the ECG to the world, he uniquely labeled its parts PQRST, inspired by mathematicians who used Ps & Qs in coordinates. Yet, he believed there was more to find, so he started in the alphabet's middle, leaving room for new discoveries on both sides.
1/n
Woah. CCR2+ myeloid cell imaging in the human heart. Can’t wait to see this applied more broadly in CV diseases. Amazing work from Lavine at al. Great example of translating mechanistic preclinical findings to humans
RESEARCH| Lavine et al. establish the feasibility of C-C chemokine receptor 2 (#CCR2) #imaging, a marker of inflammatory monocytes/macrophages, in patients that suffered a #MyocardialInfarction| @LavineLab, Yongjian Liu, @WUSTL https://t.co/wt0EcoylUm
👉https://t.co/M3bd7C36dk
First oral semaglutide made a strong impression in OASIS-1 #obesity with 15% #weightloss now orforglipron leads the impressive pack of new small molecule oral GLP-1RA with robust #Weightloss and good tolerability ADA2023
Clinical benefits of #SGLT2is in #HF do not appear to be mediated by changes in myocardial #energetics based on this small mechanistic RCT conducted in
patients with #HFrEF & #HFpEF#EMPAVISION https://t.co/KlHOrJwPgy
Join us in one week as @ThaoDVLe, graduate student in the lab of Julio Ayala (@TheBurro34), defends her thesis titled "Identification of Intracellular and Physiological Targets Transducing the Weight-Lowering Actions of Glucagon-Like Peptide 1 Receptor Agonists!"
@VanderbiltMSTP
Hypertension is the leading modifiable risk factor for worldwide morbidity & mortality. This study describes the role of T cells in hypertension & hypertensive end-organ damage & outlines potential therapeutic targets https://t.co/0QywvkDFak
@DJFehrenbach@VascRes@CVimmunology
In two weeks @smartdunc, a graduate student in the lab of Meena Madhur, will defend his thesis titled "Inflammation in hypertensive cardiac remodeling and heart failure."
We can't wait to see you there and here all about this work!